Literature DB >> 33892112

H-ferritin suppression and pronounced mitochondrial respiration make Hepatocellular Carcinoma cells sensitive to RSL3-induced ferroptosis.

Michela Asperti1, Sonia Bellini2, Elisabetta Grillo2, Magdalena Gryzik2, Luca Cantamessa2, Roberto Ronca2, Federica Maccarinelli2, Alessandro Salvi2, Giuseppina De Petro2, Paolo Arosio2, Stefania Mitola2, Maura Poli3.   

Abstract

Ferroptosis is a form of regulated cell death dependent on iron, reactive oxygen species and characterized by the accumulation of lipid peroxides. It can be experimentally initiated by chemicals, such as erastin and RSL3, that modulate GPX4 activity, the cellular antioxidant machinery that avert lipid peroxidation. The study aimed to investigate mitochondrial respiration and ferritin function as biomarkers of ferroptosis sensitivity of HepG2 and HA22T/VGH, two Hepatocellular Carcinoma (HCC) cell line models. Cell viability was determined by 3-(4,5-dimethyl-2-thiazolyl)-2,5-diphenyltetrazolium bromide (MTT) assay, labile iron levels were determined using Calcein-AM fluorescence microscopy, ferritin, glutathione and lipid peroxidation were assayed with commercially available kits. The Seahorse assay was used to investigate mitochondrial function in the cells. The study shows that highly differentiated HepG2 cells were more sensitive to RSL3-induced ferroptosis than the poorly differentiated HA22T/VGH (HCC) cell line (RSL3 IC50 0.07 μM in HepG2 vs 0.3 μM in HA22T/VGH). Interestingly, HepG2 exhibited higher mitochondrial respiration and lower glycolytic activity than HA22T/VGH and were more sensitive to RSL3-induced ferroptosis, indicating a mitochondrial-specific mechanism of action of RSL3. Interestingly, iron metabolism seems to be involved in this different sensitivity, specifically, the downregulation of H-ferritin (but not of L-subunit), makes HA22T/VGH more sensitive toward both RSL3-and iron-induced ferroptosis. Hence only the H-ferritin seems involved in the protection from this cell death process.
Copyright © 2021 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ferritin; Ferroptosis; Hepatocellular carcinoma; RSL3

Mesh:

Substances:

Year:  2021        PMID: 33892112     DOI: 10.1016/j.freeradbiomed.2021.04.024

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  10 in total

1.  Cannabinol inhibits oxytosis/ferroptosis by directly targeting mitochondria independently of cannabinoid receptors.

Authors:  Zhibin Liang; David Soriano-Castell; Devin Kepchia; Brendan M Duggan; Antonio Currais; David Schubert; Pamela Maher
Journal:  Free Radic Biol Med       Date:  2022-01-06       Impact factor: 7.376

2.  Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma.

Authors:  Chongkai Fang; Silin Liu; Kunliang Feng; Chaoyuan Huang; Ying Zhang; Jinan Wang; Hongtong Lin; Junyan Wang; Chong Zhong
Journal:  Sci Rep       Date:  2022-04-22       Impact factor: 4.996

3.  RNA-Seq Explores the Mechanism of Oxygen-Boosted Sonodynamic Therapy Based on All-in-One Nanobubbles to Enhance Ferroptosis for the Treatment of HCC.

Authors:  Yichi Chen; Haitao Shang; Chunyue Wang; Jiaqi Zeng; Shentao Zhang; Bolin Wu; Wen Cheng
Journal:  Int J Nanomedicine       Date:  2022-01-07

4.  Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer.

Authors:  Pengfei Ren; Keyan Wang; Jie Ma; Xiaoqin Cao; Jiuzhou Zhao; Chengzhi Zhao; Yongjun Guo; Hua Ye
Journal:  J Hepatocell Carcinoma       Date:  2022-03-29

5.  The NSUN5-FTH1/FTL pathway mediates ferroptosis in bone marrow-derived mesenchymal stem cells.

Authors:  Jie Liu; Zhenxing Ren; Lin Yang; Lulu Zhu; Yi Li; Caiqun Bie; Helu Liu; Yichun Ji; Dongfeng Chen; Meiling Zhu; Weihong Kuang
Journal:  Cell Death Discov       Date:  2022-03-05

Review 6.  Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.

Authors:  Dino Bekric; Matthias Ocker; Christian Mayr; Sebastian Stintzing; Markus Ritter; Tobias Kiesslich; Daniel Neureiter
Journal:  Cancers (Basel)       Date:  2022-04-04       Impact factor: 6.639

7.  Common methods in mitochondrial research (Review).

Authors:  Yiyuan Yin; Haitao Shen
Journal:  Int J Mol Med       Date:  2022-08-25       Impact factor: 5.314

Review 8.  Perspectives and mechanisms for targeting ferroptosis in the treatment of hepatocellular carcinoma.

Authors:  Lanqing Li; Xiaoqiang Wang; Haiying Xu; Xianqiong Liu; Kang Xu
Journal:  Front Mol Biosci       Date:  2022-08-16

Review 9.  Ferroptosis and Its Multifaceted Role in Cancer: Mechanisms and Therapeutic Approach.

Authors:  Heshu Chen; Chenyu Wang; Zemin Liu; Xinmiao He; Wenjie Tang; Liuqin He; Yanzhong Feng; Di Liu; Yulong Yin; Tiejun Li
Journal:  Antioxidants (Basel)       Date:  2022-07-31

10.  Identification and Validation of a Novel Ferroptotic Prognostic Genes-Based Signature of Clear Cell Renal Cell Carcinoma.

Authors:  Zhiyuan Shi; Jianzhong Zheng; Qing Liang; Yankuo Liu; Yi Yang; Rui Wang; Mingshan Wang; Qian Zhang; Zuodong Xuan; Huimin Sun; Kejia Wang; Chen Shao
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.